GlassScriptPhysician profile
Diane M Failla
NPI 1598758609
$1,636.14
in general payments reported to CMS, 2019-2025
17 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $145 · 2020: $300 · 2021: $669 · 2022: $432 · 2023: $56.65 · 2024: $33.47.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $90.12.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $90.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $245.08 | 2021-2022 | |
| Viiv Healthcare Company | $203.24 | 2020-2021 | |
| Gilead Sciences, INC. | $197.75 | 2021-2024 | |
| Theratechnologies INC. | $134.41 | 2019-2022 | |
| Amarin Pharma, INC. | $130.48 | 2021-2022 | |
| Emd Serono, INC. | $129.20 | 2019-2021 | |
| Paratek Pharmaceuticals, INC. | $107.89 | 2020-2022 | |
| Mayne Pharma Commercial LLC | $102.37 | 2021-2022 | |
| Astellas Pharma US INC | $79.74 | 2021-2022 | |
| Melinta Therapeutics, LLC | $76.49 | 2019-2022 | |
| Allergan, INC. | $63.58 | 2020 | |
| Merck Sharp & Dohme LLC | $52.55 | 2019-2021 | |
| Nabriva Therapeutics, Plc | $38.08 | 2021-2022 | |
| Janssen Pharmaceuticals, INC | $23.25 | 2021 | |
| Napo Pharmaceuticals INC | $18.79 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cumberland Pharmaceuticals, INC. | $17.12 | 2021 | |
| Kerecis Limited | $16.12 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Diane Failla listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.